We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $160M
1-Year Est. Return 8.57%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+8.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$153M
AUM Growth
+$2.13M
Cap. Flow
+$1.9M
Cap. Flow %
1.24%
Top 10 Hldgs %
48.62%
Holding
52
New
6
Increased
15
Reduced
19
Closed
6

Top Buys

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$2.97M
2
SLDB icon
Solid Biosciences
SLDB
+$2.92M
3
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$2.86M
4
TVTX icon
Travere Therapeutics
TVTX
+$2.79M
5
DOVA
Dova Pharmaceuticals, Inc. Common Stock
DOVA
+$2.77M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$2.89M
2
CORI
Corium International, Inc.
CORI
+$2.2M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$2.2M
4
KALA icon
KALA BIO
KALA
+$2.12M
5
BPMC
Blueprint Medicines
BPMC
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 49.75%
2 Financials 31.55%
3 Consumer Discretionary 7%
4 Industrials 2.82%
5 Communication Services 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRNA
51
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-179,568
Closed -$2.2M
CORI
52
DELISTED
Corium International, Inc.
CORI
– –
-274,651
Closed -$2.2M
1 2
3

Similar funds

SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
LCA
Legend Capital Advisors New York $160M AUM
SMF
Sterling Manor Financial Saratoga Springs, New York $160M AUM 13.84% 1-Year Est. Return
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return
BFAG
Blackston Financial Advisory Group The Villages, Florida $160M AUM 16.38% 1-Year Est. Return
SLG
Sanchez Levi Garrett $159M AUM

Emory University's Q3 2018 Portfolio in Review

As of Q3 2018, Emory University held 52 positions worth $153M, up 1.4% from $151M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Emory University's Q3 2018 filing shows 6 new, 15 increased, 19 reduced and 6 closed positions. Its largest new stake was Immunomedics Inc: 125,252 shares worth $2.61M. The largest sale was Abiomed Inc, an estimated $2.89M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 48% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emory University's largest Q3 2018 buy was Immunomedics Inc: 125,252 shares worth $2.61M.
  • Emory University added most to La Jolla Pharmaceutical Company in Q3 2018, an estimated $897K increase.
  • Emory University's biggest Q3 2018 reduction was Genomic Health, Inc., cutting an estimated $1.33M.
  • Emory University fully exited Abiomed Inc in Q3 2018, selling an estimated $2.89M.
  • Emory University's ten largest holdings make up 49% of its $153M portfolio in Q3 2018.
  • Emory University opened 6 new positions and closed 6 in Q3 2018.
  • Emory University's portfolio value rose 1.4% quarter-over-quarter to $153M.

Based on Emory University's 13F filing for Q3 2018, filed 14 Nov 2018.